Telomir Pharmaceuticals Touts Promising Action From Its Lead Breast Cancer Drug

All NewsOctober 9, 2025

Telomir Pharmaceuticals’ stock rises as Telomir-1 shows strong lab results against aggressive triple-negative breast cancer cells.

We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.

Cookie settings ACCEPT

Manage consent